LSBio
MAP3K8 / TPL2 Antibody

Western blot of COT expression in LPS treated 293 whole cell lysates,The lane on the left is treated with the antigen-specific peptide.

MAP3K8 / TPL2 Antibody

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Immunocytochemistry, Immunofluorescence, Immunohistochemistry (general), Western Blot
Reactivity:Human, Mouse, Rat
Format:Liquid
See all Human MAP3K8 / TPL2 antibodies →
$312.00each
Catalog Number: LS-C417522-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
TPL2 antibody LS-C417522 is an unconjugated rabbit polyclonal antibody to TPL2 (MAP3K8) from human. It is reactive with human, mouse and rat. Validated for ICC, IF, IHC and WB.
Application
ICC, IF, IHC, WB
Reactivity
Hu, Ms, Rt
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
C-COT | Cancer Osaka thyroid oncogene | COT | Ewing sarcoma transformant | EST | MAP3K8 | MEKK8 | Proto-oncogene c-Cot | TPL2 | Tumor progression locus 2 | Protein kinase cot | Tpl-2 | ESTF
Recommended Dilution: IF/ICC
1:100 - 1:500
Recommended Dilution: IHC
1:50 - 1:200
Recommended Dilution: WB
1:500 - 1:2000
UniProt Number
P41279
SwissProt
P41279

Target

Target
Human MAP3K8 / TPL2
Antigen Species
Human
Epitope
COT Antibody detects endogenous levels of total COT.
Gene Name
MAP3K8

Antibody

Host Species
Rabbit
Clonality
Polyclonal

Immunogen

Immunogen
Synthetic peptide from human COT.
Immunogen Type
Synthetic Peptide (Linear)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, pH 7.4, 150 mM NaCl, 0.02% Sodium Azide, 50% Glycerol
Volume
50 Microliter
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at -20°C for up to 1 year.
Recommended Storage Buffer
PBS|150 mM NaCl

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.